Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Return on Sales (2023 - 2025)

Historic Return on Sales for Indivior Pharmaceuticals (INDV) over the last 4 years, with Q3 2025 value amounting to 0.13%.

  • Indivior Pharmaceuticals' Return on Sales rose 600.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.11%, marking a year-over-year increase of 600.0%. This contributed to the annual value of 0.01% for FY2024, which is 1200.0% up from last year.
  • Indivior Pharmaceuticals' Return on Sales amounted to 0.13% in Q3 2025, which was up 600.0% from 0.06% recorded in Q2 2025.
  • Over the past 5 years, Indivior Pharmaceuticals' Return on Sales peaked at 0.31% during Q2 2023, and registered a low of 1.37% during Q4 2022.
  • Over the past 4 years, Indivior Pharmaceuticals' median Return on Sales value was 0.16% (recorded in 2025), while the average stood at 0.03%.
  • The largest annual percentage gain for Indivior Pharmaceuticals' Return on Sales in the last 5 years was 16000bps (2023), contrasted with its biggest fall of -11300bps (2023).
  • Over the past 4 years, Indivior Pharmaceuticals' Return on Sales (Quarter) stood at 1.37% in 2022, then skyrocketed by 117bps to 0.23% in 2023, then plummeted by -70bps to 0.07% in 2024, then surged by 90bps to 0.13% in 2025.
  • Its Return on Sales was 0.13% in Q3 2025, compared to 0.06% in Q2 2025 and 0.18% in Q1 2025.